secwatch / observer
8-K filed August 8, 2023, 7:59 PM ET ticker RYTM CIK 0001649904
leadership confidence high sentiment neutral materiality 0.45

Rhythm Pharma terminates CAO, appoints Christopher German as principal accounting officer

RHYTHM PHARMACEUTICALS, INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher German

Principal Accounting Officer
RYTM · RHYTHM PHARMACEUTICALS, INC.
Effective
2023-08-11
Filed
August 8, 2023, 7:59 PM ET
On August 8, 2023, the Board of Directors of the Company designated Christopher German, the Company’s Executive Director, Corporate Controller, as principal accounting officer, effective on the Effective Date.
Departed

William T. Roberts

Chief Accounting Officer
RYTM · RHYTHM PHARMACEUTICALS, INC.
Effective
2023-08-11
Successor
Christopher German
Filed
August 8, 2023, 7:59 PM ET
On August 4, 2023, Rhythm Pharmaceuticals, Inc. (the “Company”) notified William T. Roberts, the Company’s Chief Accounting Officer, of the termination of Mr. Roberts’ employment with the Company, to be effective on August 11, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher German was appointed as Principal Accounting Officer at RHYTHM PHARMACEUTICALS, INC..

Action
designated
Role
Principal Accounting Officer
Exact text from the filing
On August 8, 2023, the Board of Directors of the Company designated Christopher German, the Company’s Executive Director, Corporate Controller, as principal accounting officer, effective on the Effective Date.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William T. Roberts was terminated as Chief Accounting Officer at RHYTHM PHARMACEUTICALS, INC..

Action
terminated
Role
Chief Accounting Officer
Exact text from the filing
On August 4, 2023, Rhythm Pharmaceuticals, Inc. (the “Company”) notified William T. Roberts, the Company’s Chief Accounting Officer, of the termination of Mr. Roberts’ employment with the Company, to be effective on August 11, 2023
View on SEC.gov

RHYTHM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR
accession 0001104659-23-088604
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.